BC71 can be used not only as a prototype molecule for further development of GRP78 targeted peptidomimetic anticancer therapeutics but also as a radiolabeled molecule in positron emission tomography (PET) imaging to determine csGRP78 levels for cancer prognosis. Here, HSPA5 is linked to cancer.